News
Ascendis Pharma has reported week 26 interim analysis outcomes from the Phase II COACH Trial assessing TransCon CNP and ...
Amplifye, a startup led by former Amyris CEO John Melo, has launched its first product: an enzyme claimed to optimize protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback